Filing Details

Accession Number:
0001140859-22-000109
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-14 16:52:41
Reporting Period:
2022-12-12
Accepted Time:
2022-12-14 16:52:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1140859 Amerisourcebergen Corp ABC Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 233079390
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191508 H Steven Collis 1 West First Avenue
Conshohocken PA 19428
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-12 3,534 $0.00 290,967 No 5 G Direct
Common Stock Disposition 2022-12-12 33,000 $166.01 257,967 No 4 S Direct
Common Stock Acquisiton 2022-12-12 1,262 $0.00 259,229 No 4 M Direct
Common Stock Disposition 2022-12-12 1,262 $167.20 257,967 No 4 F Direct
Common Stock Acquisiton 2022-12-13 45,920 $75.61 303,887 No 4 M Direct
Common Stock Disposition 2022-12-13 38,218 $165.45 265,669 No 4 S Direct
Common Stock Disposition 2022-12-13 6,782 $166.28 258,887 No 4 S Direct
Common Stock Disposition 2022-12-13 920 $167.92 257,967 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-12-12 1,262 $0.00 1,262 $0.00
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2022-12-13 45,920 $0.00 45,920 $75.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,346 No 4 M Direct
0 2023-11-09 No 4 M Direct
Footnotes
  1. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $165.63 to $166.52, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  2. Restricted stock units received on 11/9/2022 for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025.
  3. Reflects partial lapsing of restrictions on installment scheduled to vest on 11/9/2023 to cover FICA obligation and associated income taxes for retirement eligible employees on 2022 grant of restricted stock units.
  4. The closing price of the Company's common stock on 12/12/22, the date used to calculate the FICA tax obligation in accordance with IRS rules.
  5. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $165.00 to $165.98, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  6. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.03 to $166.63, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  7. Exercisable in four equal annual installments on 11/9/2017, 11/9/2018, 11/9/2019 and 11/9/2020.